Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (CTRI/2026/09/116821) titled 'Sodium Thiosulfate for Preventing Cisplatin-Related Hearing Loss in Children: A Safety and Feasibility Study' on Sept. 1.
Study Type: Interventional
Study Design:
Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Open Label
Primary Sponsor: Deepak Bansal
Condition:
Health Condition 1: C222- Hepatoblastoma
Health Condition 2: C71- Malignant neoplasm of brain
Intervention:
Intervention1: Sodium thiosulfate: Sodium thiosulfate is efficacious for otoprotection in major clinical trials and is now an accepted c...